Back to User profile » Prof. Dr. Bernd Rosenkranz
Paper published by Prof. Dr. Bernd Rosenkranz:
Expert Opinion
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
Nachega JB, Rosenkranz B, Pham PA
Patient Preference and Adherence 2011, 5:645-651
Published Date: 28 December 2011